Panbela Therapeutics Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
PBLA
- Investments
-
2
Panbela Therapeutics General Information
Description
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X), which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity.
Contact Information
Website
www.panbela.comCorporate Office
- 712 Vista Boulevard
- Suite 305
- Waconia, MN 55387
- United States
Corporate Office
- 712 Vista Boulevard
- Suite 305
- Waconia, MN 55387
- United States
Panbela Therapeutics Stock Performance
As of 09-Nov-2026, Panbela Therapeutics’s current market cap is $971.00.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $971.00 | 3.25K |
Panbela Therapeutics Financials Summary
As of 30-Sep-2024, Panbela Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 5,861 | 10,552 | 8,227 | 9,139 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (27,444) | (25,255) | (34,775) | (10,612) |
| Net Income | (27,913) | (25,263) | (34,933) | (10,135) |
| Total Assets | 5,168 | 11,802 | 4,978 | 12,872 |
| Total Debt | 6,394 | 5,194 | 6,844 | 0 |
Panbela Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Panbela Therapeutics Comparisons
Industry
Financing
Details
Panbela Therapeutics Competitors (61)
One of Panbela Therapeutics’s 61 competitors is Aura Biosciences, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aura Biosciences | Formerly VC-backed | Boston, MA | ||||
| Statera Biopharma | Formerly VC-backed | Fort Collins, CO | ||||
| Biodexa Pharmaceuticals | Formerly PE-Backed | Cardiff, United Kingdom | ||||
| MannKind | Formerly VC-backed | Danbury, CT | ||||
| Allarity Therapeutics | Corporation | Tarpon Springs, FL |
Panbela Therapeutics Patents
Panbela Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3164914-A1 | Dosing regimens and methods for treating cancer | Pending | 20-Jan-2020 | ||
| US-20230064990-A1 | Dosing regimens and methods for treating cancer | Inactive | 20-Jan-2020 | ||
| WO-2021150559-A1 | Dosing regimens and methods for treating cancer | Inactive | 20-Jan-2020 | ||
| AU-2019213664-A1 | Methods for producing (6s,15s)-3,8,13,18-tetraazaicosane-6,15-diol | Active | 30-Jan-2018 | ||
| AU-2019213664-B2 | Methods for producing (6s,15s)-3,8,13,18-tetraazaicosane-6,15-diol | Inactive | 30-Jan-2018 | C07C213/08 |
Panbela Therapeutics Signals
Panbela Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Panbela Therapeutics Acquisitions (2)
Panbela Therapeutics’s most recent deal was a Merger/Acquisition with Cancer Prevention Pharmaceuticals for . The deal was made on 15-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cancer Prevention Pharmaceuticals | 15-Jun-2022 | Merger/Acquisition | Drug Discovery | ||
| Cimarron Software | 04-Sep-2015 | Merger/Acquisition | Other Healthcare Technology Systems |
Panbela Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Panbela Therapeutics FAQs
-
When was Panbela Therapeutics founded?
Panbela Therapeutics was founded in 2011.
-
Where is Panbela Therapeutics headquartered?
Panbela Therapeutics is headquartered in Waconia, MN.
-
What is the size of Panbela Therapeutics?
Panbela Therapeutics has 8 total employees.
-
What industry is Panbela Therapeutics in?
Panbela Therapeutics’s primary industry is Drug Discovery.
-
Is Panbela Therapeutics a private or public company?
Panbela Therapeutics is a Public company.
-
What is Panbela Therapeutics’s stock symbol?
The ticker symbol for Panbela Therapeutics is PBLA.
-
What is the current market cap of Panbela Therapeutics?
The current market capitalization of Panbela Therapeutics is $971.00.
-
Who are Panbela Therapeutics’s competitors?
Aura Biosciences, Statera Biopharma, Biodexa Pharmaceuticals, MannKind, and Allarity Therapeutics are some of the 61 competitors of Panbela Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process